Developmental screening of full-term infants at 16 to 18 months of age after in-utero exposure to maternal SARS-CoV-2 infection

J Perinatol. 2023 May;43(5):659-663. doi: 10.1038/s41372-023-01642-3. Epub 2023 Mar 17.

Abstract

Objective: To screen for neurodevelopmental delays in a cohort of full-term infants born to mothers with SARS-CoV-2.

Study design: This was a prospective, descriptive cohort study of full-term infants born to mothers with SARS-CoV-2 during pregnancy. Subjects underwent neurodevelopmental screening using the Ages and Stages Questionnaires®-Third Edition (ASQ®-3) at 16 to 18 months age.

Results: Of 51 subjects, twelve (24%) were below cutoff, and twenty-seven (53%) were either below or close to the cutoff in at least one developmental domain. Communication (29%), fine motor (31%), and problem-solving (24%) were the most affected domains. There were no differences in outcomes between infants born to asymptomatic and mildly symptomatic mothers.

Conclusion: We observed increased risk of neurodevelopmental delays during screening of infants born at full-term to mothers with SARS-CoV-2 at 16 to 18 months age. These results highlight the urgent need for follow-up studies of infants born to mothers with SARS-CoV-2.

MeSH terms

  • COVID-19* / diagnosis
  • Cohort Studies
  • Female
  • Humans
  • Infant
  • Mothers
  • Nervous System Malformations*
  • Pregnancy
  • Pregnancy Complications, Infectious* / diagnosis
  • Pregnancy Complications, Infectious* / epidemiology
  • Prospective Studies
  • SARS-CoV-2